Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.14 - $0.25 $13 - $24
-99 Reduced 1.08%
9,094 $1,000
Q1 2023

May 09, 2023

BUY
$0.23 - $0.41 $0 - $0
2 Added 0.02%
9,193 $2,000
Q4 2022

Feb 10, 2023

SELL
$0.22 - $14.5 $90 - $5,974
-412 Reduced 4.29%
9,191 $3,000
Q3 2022

Nov 10, 2022

BUY
$0.36 - $17.1 $2,670 - $126,830
7,417 Added 339.3%
9,603 $3,000
Q2 2022

Aug 15, 2022

BUY
$1.14 - $3.48 $2,101 - $6,413
1,843 Added 537.32%
2,186 $3,000
Q1 2022

May 12, 2022

SELL
$3.07 - $5.55 $5,532 - $10,001
-1,802 Reduced 84.01%
343 $1,000
Q4 2021

Feb 14, 2022

BUY
$5.12 - $14.5 $10,982 - $31,102
2,145 New
2,145 $11,000

About HELIUS MEDICAL TECHNOLOGIES, INC.


  • Ticker HSDT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,197,200
  • Market Cap $28.8M
  • Description
  • Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...
More about HSDT
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.